vs
林德（LIN）与TriSalus Life Sciences, Inc.（TLSI）财务数据对比。点击上方公司名可切换其他公司
TriSalus Life Sciences, Inc.的季度营收约是林德的1.5倍（$13.2M vs $8.8M），TriSalus Life Sciences, Inc.同比增速更快（59.8% vs 8.2%），林德自由现金流更多（$898.0K vs $-2.5M），过去两年TriSalus Life Sciences, Inc.的营收复合增速更高（43.0% vs -96.7%）
林德是全球知名跨国化工企业，按市场份额及营收计为全球最大工业气体供应商。公司1879年由德国科学家、工程师卡尔·冯·林德在德国威斯巴登创立，现总部位于英国沃金，在爱尔兰注册，2018年由原林德股份公司与1907年在美国成立的普莱克斯合并组建。
TriSalus生命科学公司是一家临床阶段生物技术企业，专注于免疫肿瘤学与介入肿瘤学领域，研发专有的靶向给药技术，用于提升肝脏、胰腺等难治性实体瘤患者的治疗效果，主要在北美市场开展临床合作及业务运营。
LIN vs TLSI — 直观对比
营收规模更大
TLSI
是对方的1.5倍
$8.8M
营收增速更快
TLSI
高出51.6%
8.2%
自由现金流更多
LIN
多$3.4M
$-2.5M
两年增速更快
TLSI
近两年复合增速
-96.7%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $8.8M | $13.2M |
| 净利润 | — | $-9.8M |
| 毛利率 | 48.5% | 86.7% |
| 营业利润率 | 27.8% | -24.8% |
| 净利率 | — | -73.9% |
| 营收同比 | 8.2% | 59.8% |
| 净利润同比 | — | 3.5% |
| 每股收益（稀释后） | $3.98 | $-0.22 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收LINTLSI
| Q1 26 | $8.8M | — | ||
| Q4 25 | $8.8B | $13.2M | ||
| Q3 25 | $8.6B | $11.6M | ||
| Q2 25 | $8.5B | $11.2M | ||
| Q1 25 | $8.1B | $9.2M | ||
| Q4 24 | $8.3B | $8.3M | ||
| Q3 24 | $8.4B | $7.3M | ||
| Q2 24 | $8.3B | $7.4M |
净利润LINTLSI
| Q1 26 | — | — | ||
| Q4 25 | $1.5B | $-9.8M | ||
| Q3 25 | $1.9B | $-10.8M | ||
| Q2 25 | $1.8B | $-8.3M | ||
| Q1 25 | $1.7B | $-10.4M | ||
| Q4 24 | $1.7B | $-10.1M | ||
| Q3 24 | $1.6B | $-2.4M | ||
| Q2 24 | $1.7B | $-4.3M |
毛利率LINTLSI
| Q1 26 | 48.5% | — | ||
| Q4 25 | — | 86.7% | ||
| Q3 25 | — | 83.5% | ||
| Q2 25 | — | 83.9% | ||
| Q1 25 | — | 83.7% | ||
| Q4 24 | — | 85.3% | ||
| Q3 24 | — | 86.3% | ||
| Q2 24 | — | 87.6% |
营业利润率LINTLSI
| Q1 26 | 27.8% | — | ||
| Q4 25 | 23.0% | -24.8% | ||
| Q3 25 | 27.5% | -77.9% | ||
| Q2 25 | 27.7% | -65.4% | ||
| Q1 25 | 26.9% | -79.9% | ||
| Q4 24 | 27.4% | -91.8% | ||
| Q3 24 | 25.0% | -118.9% | ||
| Q2 24 | 26.4% | -111.0% |
净利率LINTLSI
| Q1 26 | — | — | ||
| Q4 25 | 17.5% | -73.9% | ||
| Q3 25 | 22.4% | -93.5% | ||
| Q2 25 | 20.8% | -73.9% | ||
| Q1 25 | 20.6% | -113.2% | ||
| Q4 24 | 20.8% | -122.4% | ||
| Q3 24 | 18.5% | -32.6% | ||
| Q2 24 | 20.1% | -58.8% |
每股收益（稀释后）LINTLSI
| Q1 26 | $3.98 | — | ||
| Q4 25 | $3.28 | $-0.22 | ||
| Q3 25 | $4.09 | $-0.96 | ||
| Q2 25 | $3.73 | $-0.27 | ||
| Q1 25 | $3.51 | $-0.39 | ||
| Q4 24 | $3.61 | $-0.38 | ||
| Q3 24 | $3.22 | $-0.12 | ||
| Q2 24 | $3.44 | $-0.21 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $4.0M | $20.4M |
| 总债务越低越好 | $24.7M | — |
| 股东权益账面价值 | $40.1M | $-33.9M |
| 总资产 | $86.3M | $35.3M |
| 负债/权益比越低杠杆越低 | 0.62× | — |
8季度趋势，按日历期对齐
现金及短期投资LINTLSI
| Q1 26 | $4.0M | — | ||
| Q4 25 | $5.1B | $20.4M | ||
| Q3 25 | $4.5B | $22.7M | ||
| Q2 25 | $4.8B | $26.5M | ||
| Q1 25 | $5.3B | $13.0M | ||
| Q4 24 | $4.8B | $8.5M | ||
| Q3 24 | $5.2B | $11.3M | ||
| Q2 24 | $4.6B | $16.5M |
总债务LINTLSI
| Q1 26 | $24.7M | — | ||
| Q4 25 | $20.7B | — | ||
| Q3 25 | $18.6B | — | ||
| Q2 25 | $19.7B | — | ||
| Q1 25 | $17.6B | — | ||
| Q4 24 | $15.3B | — | ||
| Q3 24 | $17.5B | — | ||
| Q2 24 | $16.9B | — |
股东权益LINTLSI
| Q1 26 | $40.1M | — | ||
| Q4 25 | $38.2B | $-33.9M | ||
| Q3 25 | $38.6B | $-26.7M | ||
| Q2 25 | $38.5B | $-19.4M | ||
| Q1 25 | $38.0B | $-34.4M | ||
| Q4 24 | $38.1B | $-25.9M | ||
| Q3 24 | $39.2B | $-20.4M | ||
| Q2 24 | $38.2B | $-25.3M |
总资产LINTLSI
| Q1 26 | $86.3M | — | ||
| Q4 25 | $86.8B | $35.3M | ||
| Q3 25 | $86.0B | $36.5M | ||
| Q2 25 | $86.1B | $41.3M | ||
| Q1 25 | $82.7B | $28.6M | ||
| Q4 24 | $80.1B | $24.0M | ||
| Q3 24 | $82.5B | $27.5M | ||
| Q2 24 | $80.2B | $32.4M |
负债/权益比LINTLSI
| Q1 26 | 0.62× | — | ||
| Q4 25 | 0.54× | — | ||
| Q3 25 | 0.48× | — | ||
| Q2 25 | 0.51× | — | ||
| Q1 25 | 0.46× | — | ||
| Q4 24 | 0.40× | — | ||
| Q3 24 | 0.45× | — | ||
| Q2 24 | 0.44× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $-2.5M |
| 自由现金流经营现金流 - 资本支出 | $898.0K | $-2.5M |
| 自由现金流率自由现金流/营收 | 10.2% | -19.1% |
| 资本支出强度资本支出/营收 | — | 0.3% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $4.2B | $-19.1M |
8季度趋势，按日历期对齐
经营现金流LINTLSI
| Q1 26 | — | — | ||
| Q4 25 | $3.0B | $-2.5M | ||
| Q3 25 | $2.9B | $-3.7M | ||
| Q2 25 | $2.2B | $-7.3M | ||
| Q1 25 | $2.2B | $-4.5M | ||
| Q4 24 | $2.8B | $-5.7M | ||
| Q3 24 | $2.7B | $-10.8M | ||
| Q2 24 | $1.9B | $-13.4M |
自由现金流LINTLSI
| Q1 26 | $898.0K | — | ||
| Q4 25 | $1.6B | $-2.5M | ||
| Q3 25 | $1.7B | $-3.9M | ||
| Q2 25 | $954.0M | $-7.4M | ||
| Q1 25 | $891.0M | $-5.3M | ||
| Q4 24 | $1.6B | $-5.8M | ||
| Q3 24 | $1.7B | $-11.0M | ||
| Q2 24 | $796.0M | $-13.5M |
自由现金流率LINTLSI
| Q1 26 | 10.2% | — | ||
| Q4 25 | 17.9% | -19.1% | ||
| Q3 25 | 19.4% | -33.9% | ||
| Q2 25 | 11.2% | -66.1% | ||
| Q1 25 | 11.0% | -57.3% | ||
| Q4 24 | 18.8% | -69.7% | ||
| Q3 24 | 19.9% | -149.9% | ||
| Q2 24 | 9.6% | -183.1% |
资本支出强度LINTLSI
| Q1 26 | — | — | ||
| Q4 25 | 16.6% | 0.3% | ||
| Q3 25 | 14.8% | 1.9% | ||
| Q2 25 | 14.8% | 0.8% | ||
| Q1 25 | 15.7% | 8.2% | ||
| Q4 24 | 15.1% | 0.6% | ||
| Q3 24 | 12.8% | 2.3% | ||
| Q2 24 | 13.7% | 0.8% |
现金转化率LINTLSI
| Q1 26 | — | — | ||
| Q4 25 | 1.98× | — | ||
| Q3 25 | 1.53× | — | ||
| Q2 25 | 1.25× | — | ||
| Q1 25 | 1.29× | — | ||
| Q4 24 | 1.63× | — | ||
| Q3 24 | 1.76× | — | ||
| Q2 24 | 1.16× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
